Equity Details
Price & Market Data
Price: $13.14
Daily Change: -$0.11 / 0.84%
Daily Range: $13.06 - $13.40
Market Cap: $203,866,672
Daily Volume: 178,782
Performance Metrics
1 Week: 1.78%
1 Month: -1.20%
3 Months: -9.88%
6 Months: -9.88%
1 Year: -9.88%
YTD: -10.92%
About Atrium Therapeutics, Inc. (RNA)
Financial summary for Atrium Therapeutics, Inc. (RNA). Price: 13.14, daily change: -$0.11 / 0.84%. Market cap: 203,866,672. Performance for all periods at a glance.
Company Details
Employees: 511
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Atrium Therapeutics, Inc., a biopharmaceutical company, focuses on delivering ribonucleic acid (RNA) therapeutics to the heart to transform the care for people living with cardiomyopathies. The company's development stage product candidates include ATR 1072, a siRNA-based therapy targeting PRKAG2 for the treatment of PRKAG2 syndrome; and ATR 1086, a siRNA-based therapy targeting PLN for the treatment of PLN cardiomyopathy. It also focuses on pipeline to treat a range of genetic and cardiac diseases. The company was incorporated in 2025 and is headquartered in San Diego, California.